Literature DB >> 3899596

Pharmacokinetic properties of the newer cephalosporins. A valid basis for drug selection?

J T Noble, M Barza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3899596     DOI： 10.2165/00003495-198530030-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  33 in total

1.  Interaction between moxalactam and alcohol.

Authors:  H C Neu; A S Prince
Journal:  Lancet       Date:  1980-06-28       Impact factor: 79.321

2.  Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime.

Authors:  R Lüthy; J Blaser; A Bonetti; H Simmen; R Wise; W Siegenthaler
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

3.  Cefotaxime concentrations in ascites.

Authors:  L Moreau; H Durand; P Biclet
Journal:  J Antimicrob Chemother       Date:  1980-09       Impact factor: 5.790

4.  Effect of broad-spectrum cephalosporins on the microbial flora of recipients.

Authors:  G P Bodey; V Fainstein; I Garcia; B Rosenbaum; Y Wong
Journal:  J Infect Dis       Date:  1983-11       Impact factor: 5.226

Review 5.  Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  D M Richards; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

6.  Antimicrobial activity of desacetylcefotaxime alone and in combination with cefotaxime: evidence of synergy.

Authors:  R N Jones; A L Barry; C Thornsberry
Journal:  Rev Infect Dis       Date:  1982 Sep-Oct

7.  Mechanism of the inhibition of the gamma-carboxylation of glutamic acid by N-methylthiotetrazole-containing antibiotics.

Authors:  J J Lipsky
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

Review 8.  Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal function.

Authors:  R A Greenfield; A U Gerber; W A Craig
Journal:  Rev Infect Dis       Date:  1983 Mar-Apr

9.  Moxalactam--absorption, excretion, distribution, and metabolism.

Authors:  J Shimada; Y Ueda
Journal:  Rev Infect Dis       Date:  1982 Nov-Dec

Review 10.  Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; A Carmine; R C Heel; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-12       Impact factor: 9.546
View more
  6 in total

Review 1.  Current concepts in the treatment of genitourinary tract disorders in the older individual.

Authors:  A Atala; M Amin
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

2.  Dosage adjustment for ceftazidime in patients with impaired renal function.

Authors:  R van Dalen; T B Vree; A M Baars; E Termond
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 3.  Drug utilisation review (DUR) of the third generation cephalosporins. Focus on ceftriaxone, ceftazidime and cefotaxime.

Authors:  A Adu; C L Armour
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

4.  Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans.

Authors:  M Giuliano; M Barza; N V Jacobus; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

5.  Temocillin efficacy in experimental Klebsiella pneumoniae meningitis after infusion into rabbit plasma to simulate antibiotic concentrations in human serum.

Authors:  G Woodnutt; E J Catherall; I Kernutt; L Mizen
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

6.  Pharmacokinetics of cefotaxime and its desacetyl metabolite in plasma and in cerebrospinal fluid.

Authors:  E Beyssac; J M Cardot; G Colnet; J Sirot; J M Aiache
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Apr-Jun       Impact factor: 2.441
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.